Showing 1 - 7 results of 7 for search '"ВАКУУМ-АСПИРАЦИОННАЯ БИОПСИЯ"', query time: 0.49s Refine Results
  1. 1
    Academic Journal

    Contributors: the research was partially funded by a grant from the non-profit organization Foundation for the Support of Scientific Research in Oncology (RakFond) to conduct a research project in the field of oncology, with funding program code 202002. Any opinions presented in this study, the data obtained and the conclusions belong to the authors and do not necessarily reflect the opinion of the RakFond., часть работы была профинансирована грантом некоммерческой организации «Фонд поддержки научных исследований в онкологии» (РакФонд) на проведение научно-исследовательского проекта в области онкологии, код программы финансирования 2020 02. Любые представленные в работе мнения, полученные данные и выводы принадлежат авторам и не обязательно отражают мнение РакФонда.

    Source: Research and Practical Medicine Journal; Том 11, № 4 (2024); 8-22 ; Research'n Practical Medicine Journal; Том 11, № 4 (2024); 8-22 ; 2410-1893 ; 10.17709/2410-1893-2024-11-4

    File Description: application/pdf

    Relation: https://www.rpmj.ru/rpmj/article/view/1058/659; Sedeta ET, Jobre B, Avezbakiyev B. Breast cancer: Global patterns of incidence, mortality, and trends. Journal of Clinical Oncology. 2023;41(16 Suppl):10528–10528. doi:10.1200/jco.2023.41.16_suppl.10528; Злокачественные новообразования в России в 2023 году (заболеваемость и смертность). Под ред. А.Д. Каприна. М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России; 2024, 276 с. Доступно по: https://oncology-association.ru/wp-content/uploads/2024/08/zis-2023-elektronnaya-versiya.pdf Дата обращения: 22. 11. 2024; Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Long‑term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta‑analysis of individual patient data from ten randomised trials. Lancet Oncol. 2018 Jan;19(1):27–39. doi:10.1016/s1470‑2045(17)30777‑5; Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, et al. Pathological complete response and long‑term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014 Jul 12;384(9938):164–172. doi:10.1016/s0140‑6736(13)62422‑8 Erratum in: Lancet. 2019 Mar 9;393(10175):986. doi:10.1016/s0140‑6736(18)32772‑7; Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998 Aug;16(8):2672–2685. doi:10.1200/jco.1998.16.8.2672; Geng C, Chen X, Pan X, Li J. The Feasibility and Accuracy of Sentinel Lymph Node Biopsy in Initially Clinically Node‑Negative Breast Cancer after Neoadjuvant Chemotherapy : A Systematic Review and Meta‑Analysis. PLoS One. 2016 Sep 8;11(9):e0162605. doi:10.1371/journal.pone.0162605; Barrett T, Bowden DJ, Greenberg DC, Brown CH, Wishart GC, Britton PD. Radiological staging in breast cancer: which asymptomatic patients to image and how. Br J Cancer. 2009 Nov 3;101(9):1522–1528. doi:10.1038/sj.bjc.6605323; Bennett IC, Saboo A. The Evolving Role of Vacuum Assisted Biopsy of the Breast: A Progression from Fine‑Needle Aspiration Biopsy. World J Surg. 2019 Apr;43(4):1054–1061. doi:10.1007/s00268‑018‑04892‑x; van Loevezijn AA, van der Noordaa MEM, van Werkhoven ED, Loo CE, Winter‑Warnars GAO, Wiersma T, et al. Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study. Ann Surg Oncol. 2021 Jun;28(6):3243–3253. doi:10.1245/s10434‑020‑09273‑0; Vacuum Assisted Biopsy and Surgery Correlation in HER2 and TN Breast Cancer Subtypes MRI Responders After Neoadjuvant Therapy: BISUCO TRIAL NCT06371989. Доступно по: https://clinicaltrials.gov/study/NCT06371989?a=1 Дата обращения: 27. 11. 2024; Heil J, Pfob A, Sinn HP, Rauch G, Bach P, Thomas B, et al.; RESPONDER Investigators. Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5‑03. Ann Surg. 2022 Mar 1;275(3):576–581. doi:10.1097/sla.0000000000004246; Максимов К. В., Багдасарова Д. В., Зикиряходжаев А. Д., Коломейцева А. А., Мазо М. Л., Суркова В. С., и др. Изучение эффективности вакуум‑аспирационной биопсии молочной железы у больных с полным клиническим ответом после неоадъювантной полихимиотерапии в комплексном лечении рака молочной железы. Research'n Practical Medicine Journal. 2023;10(4):92–103. doi:10.17709/2410‑1893‑2023‑10‑4‑8 EDN: EDOTQS; Зикиряходжаев А. Д., Волченко Н. Н., Рожкова Н. Н., Феденко А. А., Коломейцева А. А., Максимов К. В., и др. Изучение эффективности мультифокальной биопсии молочной железы у больных с полным клиническим ответом после неоадъювантной полихимиотерапии в комплексном лечении рака молочной железы. Онкология. Журнал им. П.А. Герцена. 2022;11(6):5–11. doi:10.17116/onkolog2022110615; Максимов К. В., Багдасарова Д. В., Каприн А. Д., Зикиряходжаев А. Д., Суркова В. С., Мазо М. Л., и др. Сравнение промежуточных результатов эффективности мультифокальной биопсии и вакуум‑аспирационной биопсии молочной железы в оценке патоморфологического ответа у больных раком молочной железы с полным клиническим ответом после неоадъювантной полихимиотерапи. Вопросы онкологии. 2023;69(6):1057–1064. doi:10.37469/0507‑3758‑2023‑69‑6‑1057‑1064; Криворотько П. В., Мортада В. В., Песоцкий Р. C., Артемьева А. С., Емельянов А. С., Ерещенко С. С., и др. Точность трепанобиопсии молочной железы под ультразвуковой навигацией после неоадъювантной системной терапии для прогнозирования полного патоморфологического регресса опухоли. Опухоли женской репродуктивной системы. 2022;18(3):29–39. doi:10.17650/1994‑4098‑2022‑18‑3‑29‑39; Krivorotko PS, Yerechshenko S, Emelyanov A, Busko E, Tabagua T, Novikov S, et al. 125P De‑escalation of breast cancer surgery after neoadjuvant systemic therapy in cCR/pCR patients confirmed by vacuum‑assisted biopsy (VAB) and SLNB: A first report of the prospective non‑randomized trial results. Annals of Oncology. 2022;33:S180–S180. doi:10.1016/j.annonc.2022.03.142; Haque W, Verma V, Hatch S, Suzanne Klimberg V, Brian Butler E, Teh BS. Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy. Breast Cancer Res Treat. 2018 Aug;170(3):559–567. doi:10.1007/s10549‑018‑4801‑3; Fowler AM, Mankoff DA, Joe BN. Imaging Neoadjuvant Therapy Response in Breast Cancer. Radiology. 2017 Nov;285(2):358–375. doi:10.1148/radiol.2017170180; Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty‑year follow‑up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002 Oct 17;347(16):1233–1241. doi:10.1056/nejmoa022152; van Ramshorst MS, Loo CE, Groen EJ, Winter‑Warnars GH, Wesseling J, van Duijnhoven F, et al. MRI predicts pathologic complete response in HER2‑positive breast cancer after neoadjuvant chemotherapy. Breast Cancer Res Treat. 2017 Jul;164(1):99–106. doi:10.1007/s10549‑017‑4254‑0; Sávolt Á, Péley G, Polgár C, Udvarhelyi N, Rubovszky G, Kovács E, et al. Eight‑year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla ‑ Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early‑stage breast cancer: A randomized, single centre, phase III, non‑inferiority trial. Eur J Surg Oncol. 2017 Apr;43(4):672–679. doi:10.1016/j.ejso.2016.12.011; Hennigs A, Riedel F, Marmé F, Sinn P, Lindel K, Gondos A, et al. Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade. Breast Cancer Res Treat. 2016 Dec;160(3):491–499. doi:10.1007/s10549‑016‑4016‑4; Francis A, Herring K, Molyneux R, Jafri M, Trivedi S, Shaaban A, Rea DW. NOSTRA PRELIM: A non randomised pilot study designed to assess the ability of image guided core biopsies to detect residual disease in patients with early breast cancer who have received neoadjuvant chemotherapy to inform the design of a planned trial [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6‑10; San Antonio, TX. Philadelphia (PA): AACR. Cancer Res 2017;77(4 Suppl). doi:10.1158/1538‑7445.sabcs16‑p5‑16‑14; https://www.rpmj.ru/rpmj/article/view/1058

  2. 2
    Academic Journal

    Source: Research and Practical Medicine Journal; Том 10, № 4 (2023); 92-103 ; Research'n Practical Medicine Journal; Том 10, № 4 (2023); 92-103 ; 2410-1893 ; 10.17709/2410-1893-2023-10-4

    File Description: application/pdf

    Relation: https://www.rpmj.ru/rpmj/article/view/958/595; https://www.rpmj.ru/rpmj/article/view/958/605; Каприн А. Д., Старинский В. В., Шахзадова А. О. Состояние онкологической ̆ помощи населению России в 2021 году. М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России; 2022, 239 c. Доступно по: https://oncology-association.ru/wp-content/uploads/2022/05/sostoyanie-onkologicheskoj-pomoshhi-naseleniyu-rossii-v-2021-godu.pdf. Дата обращения: 22.11.2023.; Bennett IC, Saboo A. The Evolving Role of Vacuum Assisted Biopsy of the Breast: A Progression from Fine-Needle Aspiration Biopsy. World J Surg. 2019 Apr;43(4):1054–1061. https://doi.org/10.1007/s00268-018-04892-x; Bennett I, de Viana D, Law M, Saboo A. Surgeon-Performed Vacuum-Assisted Biopsy of the Breast: Results from a Multicentre Australian Study. World J Surg. 2020 Mar;44(3):819–824. https://doi.org/10.1007/s00268-019-05266-7; Pistolese CA, Castrignanò A, Ricci F, Meucci R, Croce G, Mondillo M, et al. Ultrasound-Guided Vacuum-Assisted Biopsy in Small Breast: A Cost-Saving Solution. Clin Breast Cancer. 2019 Apr;19(2):e352–357. https://doi.org/10.1016/j.clbc.2018.12.002; Hennigs A, Riedel F, Marmé F, Sinn P, Lindel K, Gondos A, et al. Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade. Breast Cancer Res Treat. 2016 Dec;160(3):491–499. https://doi.org/10.1007/s10549-016-4016-4; Houssami N, Macaskill P, von Minckwitz G, Marinovich ML, Mamounas E. Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy. Eur J Cancer. 2012 Dec;48(18):3342–54. https://doi.org/10.1016/j.ejca.2012.05.023; Haque W, Verma V, Hatch S, Suzanne Klimberg V, Brian Butler E, Teh BS. Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy. Breast Cancer Res Treat. 2018 Aug;170(3):559–567. https://doi.org/10.1007/s10549-018-4801-3; von Minckwitz G, Untch M, Blohmer JU, Costa SD, Eidtmann H, Fasching PA, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol. 2012 May 20;30(15):1796–804. https://doi.org/10.1200/jco.2011.38.8595; Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014 Jul 12;384(9938):164–72. https://doi.org/10.1016/s0140-6736(13)62422-8 . Erratum in: Lancet. 2019 Mar 9;393(10175):986.; Croshaw R, Shapiro-Wright H, Svensson E, Erb K, Julian T. Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients. Ann Surg Oncol. 2011 Oct;18(11):3160–3. htt ://doi.org/10.1245/s10434-011-1919-5; Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, et al. A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Ann Surg. 2018 May;267(5):946–951. https://doi.org/10.1097/sla.0000000000002313; van Loevezijn AA, van der Noordaa MEM, van Werkhoven ED, Loo CE, Winter-Warnars GAO, Wiersma T, et al. Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study. Ann Surg Oncol. 2021 Jun;28(6):3243–3253. https://doi.org/10.1245/s10434-020-09273-0; Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB) (VAB). Доступно по: https://clinicaltrials.gov/ct2/show/NCT04293796?cond=refusal+of+breast+surgery&draw=2&rank=1; Rauch GM, Kuerer HM, Adrada B, Santiago L, Moseley T, Candelaria RP, et al. Biopsy Feasibility Trial for Breast Cancer Pathologic Complete Response Detection after Neoadjuvant Chemotherapy: Imaging Assessment and Correlation Endpoints. Ann Surg Oncol. 2018 Jul;25(7):1953–1960. https://doi.org/10.1245/s10434-018-6481-y; Goldstein NS, Decker D, Severson D, Schell S, Vicini F, Margolis J, Dekhne NS. Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer. 2007 Oct 15;110(8):1687–96. https://doi.org/10.1002/cncr.22981; Heil J, Pfob A, Sinn HP, Rauch G, Bach P, Thomas B, et al.; RESPONDER Investigators. Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03. Ann Surg. 2022 Mar 1;275(3):576581. https://doi.org/10.1097/sla.0000000000004246; Tasoulis MK, Heil J, Kuerer HM. De-escalating Surgery Among Patients with HER2 + and Triple Negative Breast Cancer. Curr Breast Cancer Rep. 2022;14(4):135–141. https://doi.org/10.1007/s12609-022-00453-3; Heil J, Richter H, Golatta M, Sinn HP. Vacuum-Assisted Biopsy to Diagnose a Pathological Complete Response in Breast Cancer Patients After Neoadjuvant Systemic Therapy. Ann Surg. 2018 Dec;268(6):e60-e61. https://doi.org/10.1097/sla.0000000000002572; https://www.rpmj.ru/rpmj/article/view/958

  3. 3
  4. 4
  5. 5
  6. 6
  7. 7